High plasma nesfatin-1 level in patients with major depressive disorder

Ahima, 2000, Leptin, Annu Rev Physiol, 62, 413, 10.1146/annurev.physiol.62.1.413 Anisman, 2008, Neurotransmitter, peptides and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders, Prog Neurobiol, 85, 1, 10.1016/j.pneurobio.2008.01.004 Aydin, 2009, Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders, Mol Cell Biochem, 328, 49, 10.1007/s11010-009-0073-x Brailoiu, 2007, Nesfatin-1: distribution and interaction with a G protein coupled receptor in the rat brain, Endocrinology, 148, 5088, 10.1210/en.2007-0701 Caberlotto, 1998, Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment, Brain Res Mol Brain Res, 59, 58, 10.1016/S0169-328X(98)00137-5 Chaki, 2007, Melanocortin-4 receptor antagonists for the treatment of depression and anxiety disorders, Curr Top Med Chem, 7, 1145, 10.2174/156802607780906618 Dallman, 1995, The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at sites proximal to CRF neurons, Ann NY Acad Sci, 771, 730, 10.1111/j.1749-6632.1995.tb44724.x Domschke, 2010, Neuropeptide Y (NPY) gene: impact on emotional processing and treatment response in anxious depression, Eur Neuropsychopharmacol, 20, 301, 10.1016/j.euroneuro.2009.09.006 Erlanson-Albertsson, 2005, How palatable food disrupts appetite regulation, Basic Clin Pharmacol Toxicol, 97, 61, 10.1111/j.1742-7843.2005.pto_179.x Goebel, 2009, Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats, Brain Res, 1300, 114, 10.1016/j.brainres.2009.08.082 Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Koob, 1999, A role for corticotropin releasing factor and urocortin in behavioral responses to stressors, Brain Res, 848, 141, 10.1016/S0006-8993(99)01991-5 Kranz, 2010, Reward and the serotonergic system, Neuroscience, 166, 1023, 10.1016/j.neuroscience.2010.01.036 Leal, 1997, Food and the circadian activity of the hypothalamic–pituitary–adrenal axis, Braz J Med Biol Res, 30, 1391, 10.1590/S0100-879X1997001200003 Leonard, 1997, The role of noradrenaline in depression: a review, J Psychopharmacol, 11, S39 Li, 2010, Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans, Regul Pept, 159, 72, 10.1016/j.regpep.2009.11.003 Merali, 2008, Nesfatin-1 increases anxiety- and fear-related behaviors in the rat, Psychopharmacology, 201, 115, 10.1007/s00213-008-1252-2 Merali, 1998, Aversive and appetitive events evoke the release of corticotropinreleasing hormone and bombesin-like peptides at the central nucleus of the amygdala, J Neurosci, 18, 4758, 10.1523/JNEUROSCI.18-12-04758.1998 Oh, 2006, Identification of nesfatin-1 as a satiety molecule in the hypothalamus, Nature, 443, 709, 10.1038/nature05162 Pan, 2007, Nesfatin-1 crosses the blood-brain barrier without saturation, Peptides, 28, 2223, 10.1016/j.peptides.2007.09.005 Pecoraro, 2004, Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress, Endocrinology, 145, 3754, 10.1210/en.2004-0305 Price, 2007, Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1, Peptides, 28, 2372, 10.1016/j.peptides.2007.10.008 Price, 2008, Nesfatin-1 inhibits NPY neurons in the arcuate nucleus, Brain Res, 1230, 99, 10.1016/j.brainres.2008.06.084 Ramanjaneya, 2010, Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity, Endocrinology, 151, 3169, 10.1210/en.2009-1358 Rao, 2003, GABAergic agents prevent alpha-melanocyte stimulating hormone induced anxiety and anorexia in rats, Pharmacol Biochem Behav, 76, 417, 10.1016/j.pbb.2003.08.016 Rotzinger, 2010, Behavioral effects of neuropeptides in rodent models of depression and anxiety, Peptides, 31, 736, 10.1016/j.peptides.2009.12.015 Spinazzi, 2006, Orexins in the regulation of the hypothalamic–pituitary–adrenal axis, Pharmacol Rev, 58, 46, 10.1124/pr.58.1.4 Tannenbaum, 1997, High-fat feeding alters both basal and stress-induced hypothalamic–pituitary–adrenal activity in the rat, Am J Physiol, 273, E1168 Tsuchiya, 2010, Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males, Clin Endocrinol, 73, 484 Ueta, 2003, Involvement of novel feeding-related peptides in neuroendocrine response to stress, Exp Biol Med, 228, 1168, 10.1177/153537020322801011